The neuroendocrine effects of traumatic brain injury

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 19, Issue 4, 2007, Pages 363-372

  Rothman, Micol S ^a,b   Arciniegas, David B ^b,c,e   Filley, Christopher M ^b,c,d   Wierman, Margaret E ^a,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e HealthONE Spalding Rehabilitation Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PROLACTIN; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE; TESTOSTERONE; TETRACOSACTIDE; THYROTROPIN;

CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COGNITION; COGNITIVE DEFECT; CORTICOTROPIN DEFICIENCY; DISEASE ASSOCIATION; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; GLASGOW COMA SCALE; GONADOTROPIN DEFICIENCY; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS; HYPOPHYSIS FUNCTION; HYPOPHYSIS GONAD SYSTEM; INCIDENCE; NEUROENDOCRINE DISEASE; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; TRAUMATIC BRAIN INJURY;

EID: 36348970491     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2007.19.4.363     Document Type: Review

References (71)

1. Bondanelli M, Ambrosio MR, Zatelli MC, et al: Hypopituitarism after traumatic brain injury. Eur J Endocrinol 2005; 152:679-691
2. Popovic V, Aimaretti G, Casanueva FF, et al: Hypopituitarism following traumatic brain injury. Growth Horm IGF Res 2005; 15:177-184
3. Agha A, Rogers B, Mylotte D, et al: Neuroendocrine dysfunction in the acute phase of traumatic brain injury. Clin Endocrinol (Oxf) 2004; 60:584-591
4. Leal-Cerro A, Flores JM, Rincon M, et al: Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury. Clin Endocrinol (Oxf) 2005; 62:525-532
5. Lieberman SA, Oberoi AL, Gilkison CR, et al: Prevalence of neuroendocrine dysfunction in patients recovering from traumatic brain injury. J Clin Endocrinol Metab 2001; 86:2752-2756
6. Dimopoulou I, Tsagarakis S, Theodorakopoulou M, et al: Endocrine abnormalities in critical care patients with moderate-to-severe head trauma: incidence, pattern and predisposing factors. Intensive Care Med 2004; 30:1051-1057
7. Bondanelli M, De Marinis L, Ambrosio MR, et al: Occurrence of pituitary dysfunction following traumatic brain injury. J Neurotrauma 2004; 21:685-696
8. Aimaretti G, Ambrosio MR, Di Somma C, et al: Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol (Oxf) 2004; 61:320-326
9. Agha A, Rogers B, Sherlock M, et al: Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab 2004; 89:4929-4936
10. Kelly DF, Gonzalo IT, Cohan P, et al: Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg 2000; 93:743-752
11. Lee SC, Zasler ND, Kreutzer JS: Male pituitary-gonadal dysfunction following severe traumatic brain injury. Brain Inj 1994; 8:571-577
12. Clark JD, Raggatt PR, Edwards OM: Abnormalities of the hypothalamo-pituitary-gonadal axis after head injury. Clin Endocrinol (Oxf) 1992; 36:481-485
13. Aimaretti G, Ambrosio MR, Di Somma C, et al: Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab 2005; 90:6085-6092
14. Benvenga S, Campenni A, Ruggeri RM, et al: Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab 2000; 85:1353-1361
15. Langlois J, Rutland-Brown W, Thomas K: Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths. Atlanta, Ga, Centers for Disease Control and Prevention, National Center for Injury Prevention, 2004
16. McAllister TW, Arciniegas D: Evaluation and treatment of post-concussive symptoms. NeuroRehabilitation 2002; 17:265-283
17. Raghupathi R: Cell death mechanisms following traumatic brain injury. Brain Pathol 2004; 14:215-222
18. Butler TL, Kassed CA, Pennypacker KR: Signal transduction and neurosurvival in experimental models of brain injury. Brain Res Bull 2003; 59:339-351
19. Gaetz M: The neurophysiology of brain injury. Clin Neurophysiol 2004; 115:4-18
20. Dutton RP, McCunn M: Traumatic brain injury. Curr Opin Crit Care 2003; 9:503-509
21. Goldstein LB: Neuropharmacology of TBI-induced plasticity. Brain Inj 2003; 17:685-694
22. Casanueva FF, Ghigo E, Popovic V: Hypopituitarism following traumatic brain injury (TBI): a guideline decalogue. J Endocrinol Invest 2004; 27:793-795
23. Popovic V: Growth hormone deficiency as the most common pituitary defect after TBI: clinical implications. Pituitary 2005; 8:239-243
24. Woolf PD, Hamill RW, McDonald JV, et al: Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985; 60:444-450
25. Childers MK, Rupright J, Jones PS, et al: Assessment of neuroendocrine dysfunction following traumatic brain injury. Brain Inj 1998; 12:517-523
26. Agha A, Phillips J, O'Kelly P, et al: The natural history of post-traumatic hypopituitarism: implications for assessment and treatment. Am J Med 2005; 118:1416
27. Mechanick JI, Nierman DM: Gonadal steroids in critical illness. Crit Care Clin 2006; 22:87-103, vii
28. Spratt DI, Bigos ST, Beitins I, et al: Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: bioand immunoactive gonadotropins. J Clin Endocrinol Metab 1992; 75:1562-1570
29. Spratt DI, Cox P, Orav J, et al: Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metab 1993; 76:1548-1554
30. Nierman DM, Mechanick JI: Hypotestosteronemia in chronically critically ill men. Crit Care Med 1999; 27:2418-2421
31. Ferrando AA, Sheffield-Moore M, Wolf SE, et al: Testosterone administration in severe burns ameliorates muscle catabolism. Crit Care Med 2001; 29:1936-1942
32. Stein DG: Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci 2001; 24:386-391
33. Azcoitia I, Sierra A, Veiga S, et al: Aromatase expression by reactive astroglia is neuroprotective. Ann N Y Acad Sci 2003; 1007:298-305
34. McEwen BS: Clinical review 108: The molecular and neuroanatomical basis for estrogen effects in the central nervous system. J Clin Endocrinol Metab 1999; 84:1790-1797
35. Vegeto E, Belcredito S, Etteri S, et al: Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci U S A 2003; 100:9614-9619
36. Yaffe K, Lui LY, Zmuda J, et al: Sex hormones and cognitive function in older men. J Am Geriatr Soc 2002; 50:707-712
37. Wolf OT, Kirschbaum C: Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav 2002; 41:259-266
38. Moffat SD, Zonderman AB, Metter EJ, et al: Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 2002; 87:5001-5007
39. Yaffe K, Lui LY, Grady D, et al: Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet 2000; 356:708-712
40. O'Connor DB, Archer J, Hair WM, et al: Activational effects of testosterone on cognitive function in men. Neuropsychologia 2001; 39:1385-1394
41. Ko YH, Joe SH, Cho W, et al: Estrogen, cognitive function and negative symptoms in female schizophrenia. Neuropsychobiology 2006; 53:169-175
42. Bhasin S, Storer TW, Berman N, et al: Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997; 82:407-413
43. Bhasin S, Storer TW, Asbel-Sethi N, et al: Effects of testosterone replacement with a nongenital, transdermal system, androderm, in human immunodeficiency virus-infected men with low testosterone levels. J Clin Endocrinol Metab 1998; 83:3155-3162
44. Grinspoon S, Corcoran C, Parlman K, et al: Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting: a randomized, controlled trial. Ann Intern Med 2000; 133:348-355
45. Greenspan FS, Gardner DG: Basic and Clinical Endocrinology, 7th ed. New York, McGraw-Hill, 2004
46. Ghigo E, Masel B, Aimaretti G, et al: Consensus guidelines on screening for hypopituitarism following traumatic brain injury. Brain Inj 2005; 19:711-724
47. Scheepens A, Sirimanne ES, Breier BH, et al: Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience 2001; 104:677-687
48. Salomon F, Cuneo RC, Hesp R, et al: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989; 321:1797-1803
49. Jorgensen JO, Pedersen SA, Thuesen L, et al: Beneficial effects of growth hormone treatment in growth hormone-deficient adults. Lancet 1989; 1:1221-1225
50. Whitehead HM, Boreham C, McIlrath EM, et al: Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) 1992; 36:45-52
51. Carroll PV, Christ ER, Bengtsson BA, et al: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review, growth hormone research society scientific committee. J Clin Endocrinol Metab 1998; 83:382-395
52. Jiang ZM, He GZ, Zhang SY, et al: Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg 1989; 210:513-524, discussion 524-525
53. Knox JB, Wilmore DW, Demling RH, et al: Use of growth hormone for postoperative respiratory failure. Am J Surg 1996; 171:576-580
54. Takala J, Ruokonen E, Webster NR, et al: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341:785-792
55. Cernak I, Savic VJ, Lazarov A, et al: Neuroendocrine responses following graded traumatic brain injury in male adults. Brain Inj 1999; 13:1005-1015
56. Savaridas T, Andrews PJ, Harris B: Cortisol dynamics following acute severe brain injury. Intensive Care Med 2004; 30:1479-1483
57. Dimopoulou I, Tsagarakis S, Kouyialis AT, et al: Hypothalamic-pituitary- adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels. Crit Care Med 2004; 32:404-408
58. Dickstein G, Shechner C, Nicholson WE, et al: Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991; 72:773-778
59. Rasmuson S, Olsson T, Hagg E: A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 1996; 44:151-156
60. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003; 31:141-145
61. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
62. Hamrahian AH, Oseni TS, Arafah BM: Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350:1629-1638
63. Chinga-Alayo E, Villena J, Evans AT, et al: Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit. Intensive Care Med 2005; 31:1356-1361
64. Becker RA, Vaughan GM, Ziegler MG, et al: Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 1982; 10:870-875
65. Brent GA, Hershman JM: Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63:1-8
66. Reichlin S: Neuroendocrinology. Williams Textbook of Endocrinonology. Philadelphia, WB Saunders and Co, 1992, pp 174-175
67. Maruff P, Falleti M: Cognitive function in growth hormone deficiency and growth hormone replacement. Horm Res 2005; 64(suppl 3):100-108
68. Azad N, Pitale S, Barnes WE, et al: Testosterone treatment enhances regional brain perfusion in hypogonadal men. J Clin Endocrinol Metab 2003; 88:3064-308
69. Biller BM, Samuels MH, Zagar A, et al: Sensitivity and specificity of six tests for the diagnosis of adult growth hormone deficiency. J Clin Endocrinol Metab 2002; 87:2067-2079
70. Popovic V, Leal A, Micic D, et al: Growth hormone-releasing hormone and growth hormone-releasing peptide-6 for diagnostic testing in growth hormone-deficient adults. Lancet 2000; 356:1137-1142
71. May ME, Carey RM: Rapid adrenocorticotropic hormone test in practice: retrospective review. Am J Med 1985; 79:679-684